WHO prequalifies Takeda’s dengue vaccine

In February 2024, it was announced that Takeda Pharma would partner with Biological E to make 50 million dengue vaccines.

BySouth First Desk

Published May 16, 2024 | 10:15 PMUpdatedMay 16, 2024 | 10:15 PM

covid-19 vaccine

The World Health Organisation on Wednesday, 15 May, announced that it had prequalified a new vaccine for dengue, making TAK-003 the second dengue vaccine to be prequalified by it. Developed by Japanese multinational pharmaceutical company Takeda, it is a live-attenuated vaccine containing weakened versions of the four serotypes of the virus that cause dengue.

Read the full story here